Bionic Sight Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4


  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Bionic Sight General Information


Developer of a medical device designed to develop and commercialize prosthetic treatments for blindness due to retinal degenerative disease. The company's device uses retinal code that can convert visual images into similar patterns of an action potential that the retina normally produces and can do so across a broad range of stimuli including faces, landscapes, and movement, essentially replicating patterns in a code the brain is expecting and can recognize, enabling users to bring prosthetic capabilities up to the level of near-normal image representation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • 430 East 63rd Street
  • Apartment 2-G
  • New York, NY 10065
  • United States
+1 (646) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bionic Sight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Feb-2023 000 Completed Clinical Trials - General
2. Later Stage VC 01-Mar-2020 000 000 Completed Clinical Trials - General
1. Early Stage VC 01-Jan-2014 Completed Clinical Trials - General
To view Bionic Sight’s complete valuation and funding history, request access »

Bionic Sight Executive Team (2)

Name Title Board Seat Contact Info
Sheila Nirenberg Ph.D Co-Founder & Principal
William Hauswirth Ph.D Co-Founder
To view Bionic Sight’s complete executive team members history, request access »

Bionic Sight Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bionic Sight Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Samsara BioCapital Venture Capital Minority 000 0000 000000 0
Beacon Therapeutics Corporation Minority 000 0000 000000 0
Partnership Fund for New York City Impact Investing Minority 000 0000 000000 0
To view Bionic Sight’s complete investors history, request access »

Bionic Sight FAQs

  • When was Bionic Sight founded?

    Bionic Sight was founded in 2012.

  • Who is the founder of Bionic Sight?

    Sheila Nirenberg Ph.D and William Hauswirth Ph.D are the founders of Bionic Sight.

  • Where is Bionic Sight headquartered?

    Bionic Sight is headquartered in New York, NY.

  • What is the size of Bionic Sight?

    Bionic Sight has 4 total employees.

  • What industry is Bionic Sight in?

    Bionic Sight’s primary industry is Therapeutic Devices.

  • Is Bionic Sight a private or public company?

    Bionic Sight is a Private company.

  • What is Bionic Sight’s current revenue?

    The current revenue for Bionic Sight is 000000.

  • How much funding has Bionic Sight raised over time?

    Bionic Sight has raised $2M.

  • Who are Bionic Sight’s investors?

    Samsara BioCapital, Beacon Therapeutics, and Partnership Fund for New York City have invested in Bionic Sight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »